SEC Form 4 · accession 0001258693-26-000015

Vaxcyte, Inc. · PCVX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Grant Pickering

Officer — CHIEF EXECUTIVE OFFICER · Director

Period of report

Jul 27, 2026

Accepted (ET)

Jul 28, 2026 · 4:10 pm EDT

Rule 10b5-1 plan

yes — trade under a plan

Issuer CIK

0001649094

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jul 27, 2026	M	16,198	$2.03	A	469,445	D
Common Stock^F3	Jul 27, 2026	S	11,783	$55.515	D	457,662	D
Common Stock^F4	Jul 27, 2026	S	4,415	$55.931	D	453,247	D
Common Stock^F5,F6	Jul 27, 2026	S	756	$55.516	D	133,459	I	By Children's Trust
Common Stock^F7,F6	Jul 27, 2026	S	244	$55.964	D	133,215	I	By Children's Trust
Common Stock^F5,F8	Jul 27, 2026	S	622	$55.54	D	133,593	I	By Children's Trust
Common Stock^F9,F8	Jul 27, 2026	S	378	$55.914	D	133,215	I	By Children's Trust

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F10	$2.03	Jul 27, 2026	M	16,198	D	—	Jul 24, 2028	Common Stock	16,198	137,000	D

Explanation of responses

F1Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
F10Option is fully vested and exercisable.
F2The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 3, 2026.
F3The price reported is a weighted-average price. The shares were sold at prices ranging from $54.77 to $55.765. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4The price reported is a weighted-average price. The shares were sold at prices ranging from $55.77 to $56.13. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5The price reported is a weighted-average price. The shares were sold at prices ranging from $54.77 to $55.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6Shares are held directly by a trust for the benefit of the Reporting Person's son.
F7The price reported is a weighted-average price. The shares were sold at prices ranging from $55.81 to $56.18. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F8Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
F9The price reported is a weighted-average price. The shares were sold at prices ranging from $55.82 to $56.085. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.